News

Total sleep time was increased in the Ambien CR group throughout the study. At week eight, patients reporting sleeping an average of 101 minutes more than baseline compared

The primary objective of the double blind, placebo controlled, crossover trial is to assess the efficacy of two different dose strengths of AZD3480 in adult subjects diagnosed with

As previously announced, the purchase price was $2.4 million, part paid on closing and part subject to achievement of certain milestones. In order to partially fund the acquisition,

Dr McCormack has more than 20 years experience in medical technologies, from fundamental research to product development. He was previously a partner of Global Life Science Ventures (GLSV)

This new sponsored research will focus on the development of a new novel class of compounds that inhibit glycolysis, the metabolic pathway essential to the survival of many

With this acquisition, Miltenyi Biotec strengthens the portfolio in the area of sample preparation. The additional expertise of Medic Tools enables Miltenyi Biotec to further engage in development

Mylan launched its Omeprazole products on August 4, 2003, despite the patent infringement litigation, which at the time was unprecedented in the generic pharmaceutical industry. Robert Coury, vice

The joint work of the two companies will focus on educational and cross-promotional efforts intended to benefit the patients and healthcare professionals served by both companies. The goal

Based on Durect’s Oradur technology, Remoxy is designed to resist common methods of prescription drug misuse and abuse. Remoxy is being developed by Pain Therapeutics under license from